Subscribe to RSS
Download PDF
DOI: 10.1160/TH12-09-0709
Reticulated platelets predict cardiovascular death in acute coronary syndrome patients
Insights from the AMI-Florence 2 StudyPublication History
Received:
28 September 2012
Accepted after major revision:
01 March 2013
Publication Date:
22 November 2017 (online)
Summary
Reticulated platelets (RP) are newly-formed platelets with a greater mass, a residual amount of RNA and an increased prothrombotic potential. No studies investigating the association between RP and the risk of cardiovascular death in acute coronary syndrome (ACS) patients are available. In the frame of the AMI-Florence 2 study, we investigated RP in 229 (154 M/ 75 F) ACS patients (125 ST-elevation myocardial infarction [STEMI]; 104 Non-STEMI/Unstable Angina). RP were measured by using the Sysmex XE-2100 haematology analyzer and were expressed as the percentage of RP out of the total optical platelet count (immature platelet fraction; IPF) and as the percentage of RP highly fluorescent (H-IPF). At one-year follow-up, 22 out of 229 patients (9.6%) died from cardiovascular causes. Higher values of IPF (p=0.05) and H-IPF (p=0.006) were detected in dead compared to alive patients. A receiver operating characteristics curve analysis identified IPF ≥3.3% and H-IPF ≥0.9% as optimal cut-off values to predict cardiovascular death. At the multivariate model adjusted for the Global Registry of Acute Coronary Events (GRACE) risk score, the association between RP and cardiovascular death remained significant for both IPF [OR (95%CI) : 4.15 (1.24–13.91) p=0.02] and H-IPF [OR (95%CI): H-IPF 5.03 (1.38–18.38) p=0.01]. In conclusion, RP are independent predictors of cardiovascular death and may be useful in improving risk stratification for ACS patients. Future prospective studies to evaluate the role of RP in determining cardiovascular events are warranted.
-
References
- 1 Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005; 115: 3378-3384.
- 2 Sofi F, Marcucci R, Gori AM. et al. Clopidogrel non responsiveness and risk of cardiovascular morbidity. An updated meta-analysis. Thromb haemost 2010; 103: 841-848.
- 3 Parodi G, Marcucci R, Valenti R. et al. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. J Am Med Assoc 2011; 306: 1215-1223.
- 4 Karpatkin S. Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest 1969; 48: 1083-1087.
- 5 Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J 2001; 22: 1561-1571.
- 6 Harrison P, Goodall AH. “Message in the platelet” – more than just vestigial mRNA. Platelets 2008; 19: 395-404.
- 7 Monteagudo Jimenez M, Amengual Guedan MJ, Munoz Martin L. et al. Measurement of reticulated platelets by simple flow cytometry: an indirect thrombocytopoietic marker. Eur J Int Med 2006; 17: 541-544.
- 8 Saxon BR, Blanchette VS, Butchard S. et al. Reticulated platelets count in the diagnosis of acute immune thrombocytopenic purpura. J Pediatric Hematol Oncol 1998; 20: 44-48.
- 9 Kurata Y, Hayashi S, Kiyoi T. et al. Diagnostic value test for reticulated platelets, plasma glycocalicin and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia. Am J Clin Pathol 2001; 115: 656-664.
- 10 Nakamura T, Uchiyama S, Yamazaki M. et al. Flow cytometric analysis of reticulated platelets in patients with ischemic stroke. Thromb Res 2002; 106: 171-177.
- 11 Würtz M, Grove EL, Wulff LN. et al. Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets. JACC Cardiovasc Interv 2010; 03: 828-835.
- 12 Lakkis N, Dokainish H, Abuzahara M. et al. Reticulated platelets in acute coronary syndrome: a marker of platelet activity. J Am Coll Cardiol 2004; 10: 2087-2098.
- 13 Cesari F, Marcucci R, Caporale R. et al. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Thromb Haemost 2008; 99: 930-935.
- 14 Guthikonda S, Alviar CL, Vaduganathan M. et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 2008; 52: 743-749.
- 15 Grove EL, Hvas AM, Mortensen SB. et al. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease. J Thromb Haemost 2011; 09: 185-191.
- 16 Würtz M, Wulff LN, Grove EL. et al. Influence of renal function and platelet turnover on the antiplatelet effect of aspirin. Thromb Res 2012; 129: 434-440.
- 17 Hamm CW, Bassand JP, Agewall S. et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2011; 32: 2999-3054.
- 18 Cifkova R, Erdine S, Fagard R. et al. ESH/ESC Hypertension Guidelines Committee Practice guidelines for primary care physicians: 2003 ESH/ESC Hypertension guidelines. J Hypertens 2003; 21: 1779-1786.
- 19 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care. 2003 26. 5-20.
- 20 Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adult (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143-3421.
- 21 Briggs C, Kunka S, Hart D. et al. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004; 126: 93-99.
- 22 Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in the elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 1992; 14: 281-287.
- 23 Papanas N, Symeonidis G, Maltezos E. et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15: 475-478.
- 24 Jakubowski JA, Thompson CB, Vaillancourt R. et al. Arachidonic acid metabolism by platelets of differing size. Br J Haematol 1983; 53: 503-511.
- 25 Grove EL, Hvas AM, Kristensen SD. Immature platelets in patients with acute coronary syndromes. Thromb Haemost 2009; 101: 151-156.
- 26 Martin JF, Trowbridge EA, Salmon GL. et al. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nucler DNA concentration. Thromb Res 1983; 32: 443-460.
- 27 Tschoepe D, Roesen P, Kauffmann L. et al. Evidence for abnormal platelet glycoprotein expression in diabetes mellitus. Eur J Clin Invest 1990; 20: 166-170.
- 28 Watala C. Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus. Curr Pharm Des 2005; 11: 2331-2365.
- 29 Guthikonda S, Lev EI, Patel R. et al. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 2007; 05: 490-496.
- 30 Perneby C, Wallen NH, Rooney C. et al. Dose and time-dependent antiplatelet effects of aspirin. Thromb Haemost 2006; 95: 652-658.
- 31 Chu SG, Becker RC, Berger PB. et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. Thromb Haemost 2010; 08: 148-156.
- 32 Papanas N, Symeonidis G, Maltezos E. et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15: 475-478.
- 33 Nadar S, Blann AD, Lip GY. Platelet morphology and plasma indices of platelet activation in essential hypertension: effects of amlodipine-based antihypertensive therapy. Ann Med 2004; 36: 552-557.
- 34 Pathansali R, Smith N, Bath P. altered megakaryocyte-platelet haemostatic axis in hypercholesterolemia. Platelets 2001; 12: 292-297.
- 35 Kario K, Matsuo T, Nakao K. Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis. Clin Lab Haematol 1992; 14: 281-287.
- 36 Coban E, Ozdogan M, Yazicioglu G. et al. The mean platelet volume in patients with obesity. Int J Clin Pract 2005; 59: 981-982.
- 37 Brambilla M, Camera M, Colnago D. et al. Tissue factor in patients with acute coronary syndromes: expression in platelets, leukocytes, and platelet-leukocyte aggregates. Arterioscler Thromb vasc Biol 2008; 28: 947-953.
- 38 Lindemann S, Tolley ND, Dixon DA. et al. Activated platelets mediate inflammatory signalling by regulated interleukin 1 synthesis. J Cell Biol 2001; 154: 485-490.
- 39 Matic GB, Chapman ES, Zaiss M. et al. Whole blood analysis of reticulated platelets: improvements of detection and assay stability. Cytometry 1998; 34: 229-234.